Adler S, Waterman M L, He X, Rosenfeld M G
Center for Molecular Genetics, University of California, San Diego, La Jolla 92093-0613.
Cell. 1988 Mar 11;52(5):685-95. doi: 10.1016/0092-8674(88)90406-0.
Prolactin gene expression is negatively regulated by glucocorticoids, and by estrogens when positive estrogen regulatory elements in the prolactin gene are removed. Mutational analysis of estrogen receptor confirms that inhibition is a function of receptor, and that transcriptional activation and inhibition require distinct, separable structural elements. Inhibition is dependent on a 63 amino acid region (amino acids 251-314) distinct from the DNA-binding and steroid-binding domains. The comparable region of glucocorticoid receptor confers inhibitory actions on a hybrid receptor. Multiple, nonoverlapping sequences in the rat prolactin 5'-flanking genomic region that confer inhibition by both steroid hormones contain related cis-active elements that bind a common, tissue-specific positive transcription factor, called Pit-1. Experimental results indicate that positive and negative transcriptional effects of estrogen receptor are mediated by separate functional domains, and suggest the protein-protein interactions between steroid hormone receptors and other transcription factor(s) mediate inhibition.
催乳素基因表达受糖皮质激素负调控,当催乳素基因中的正性雌激素调节元件被去除时,也受雌激素负调控。雌激素受体的突变分析证实,抑制作用是受体的一种功能,并且转录激活和抑制需要不同的、可分离的结构元件。抑制作用依赖于一个与DNA结合域和类固醇结合域不同的63个氨基酸区域(氨基酸251 - 314)。糖皮质激素受体的类似区域赋予杂合受体抑制作用。大鼠催乳素5'侧翼基因组区域中多个不重叠的序列,可被两种类固醇激素抑制,这些序列含有相关的顺式作用元件,可结合一种共同的、组织特异性的正性转录因子,称为Pit-1。实验结果表明,雌激素受体的正性和负性转录作用由不同的功能域介导,并提示类固醇激素受体与其他转录因子之间的蛋白质-蛋白质相互作用介导了抑制作用。